1. Home
  2. ISPC vs CHEK Comparison

ISPC vs CHEK Comparison

Compare ISPC & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISPC
  • CHEK
  • Stock Information
  • Founded
  • ISPC 2009
  • CHEK 2004
  • Country
  • ISPC United States
  • CHEK Israel
  • Employees
  • ISPC N/A
  • CHEK N/A
  • Industry
  • ISPC Precision Instruments
  • CHEK Medical Electronics
  • Sector
  • ISPC Health Care
  • CHEK Health Care
  • Exchange
  • ISPC Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • ISPC 4.7M
  • CHEK 5.1M
  • IPO Year
  • ISPC 2021
  • CHEK 2015
  • Fundamental
  • Price
  • ISPC $4.20
  • CHEK $0.80
  • Analyst Decision
  • ISPC
  • CHEK
  • Analyst Count
  • ISPC 0
  • CHEK 0
  • Target Price
  • ISPC N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • ISPC 954.4K
  • CHEK 29.4K
  • Earning Date
  • ISPC 11-07-2024
  • CHEK 11-25-2024
  • Dividend Yield
  • ISPC N/A
  • CHEK N/A
  • EPS Growth
  • ISPC N/A
  • CHEK N/A
  • EPS
  • ISPC N/A
  • CHEK N/A
  • Revenue
  • ISPC $10,390,702.00
  • CHEK N/A
  • Revenue This Year
  • ISPC $13.82
  • CHEK N/A
  • Revenue Next Year
  • ISPC $11.76
  • CHEK N/A
  • P/E Ratio
  • ISPC N/A
  • CHEK N/A
  • Revenue Growth
  • ISPC 0.74
  • CHEK N/A
  • 52 Week Low
  • ISPC $3.41
  • CHEK $0.76
  • 52 Week High
  • ISPC $12.60
  • CHEK $3.62
  • Technical
  • Relative Strength Index (RSI)
  • ISPC 44.46
  • CHEK 21.50
  • Support Level
  • ISPC $4.19
  • CHEK $0.80
  • Resistance Level
  • ISPC $4.83
  • CHEK $1.28
  • Average True Range (ATR)
  • ISPC 0.57
  • CHEK 0.08
  • MACD
  • ISPC -0.02
  • CHEK -0.02
  • Stochastic Oscillator
  • ISPC 38.16
  • CHEK 7.57

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: